The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
Open Access
- 2 August 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5311
Abstract
Genetic changes along with environmental exposures can play a role in the development of cancer. Individuals with significant risk factors for breast cancer including family history should be encouraged to undergo genetic testing along with breast cancer screening at an early age. Individuals who test positive for the breast cancer (BRCA) 1 or 2 gene can discuss potential risk-reducing management options, such as risk-reducing prophylactic mastectomy, with their physicians in order to protect them from the long-term consequences of developing breast cancer.Keywords
This publication has 8 references indexed in Scilit:
- Progression from ductal carcinoma in situ to invasive breast cancer: RevisitedMolecular Oncology, 2013
- Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisAnnals of Oncology, 2013
- Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskInternational Journal of Cancer, 2013
- Prophylactic mastectomy and the timing of breast reconstructionBritish Journal of Surgery, 2009
- Prevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic WhitesCancer Epidemiology, Biomarkers & Prevention, 2004
- Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA MutationsJournal of Clinical Oncology, 2003
- Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation CarriersJournal of Clinical Oncology, 2002
- Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001